Literature DB >> 17623660

Persistent and stable gene expression by a cytoplasmic RNA replicon based on a noncytopathic variant Sendai virus.

Ken Nishimura1, Hiroaki Segawa, Takahiro Goto, Mariko Morishita, Akinori Masago, Hitoshi Takahashi, Yoshihiro Ohmiya, Takemasa Sakaguchi, Masahiro Asada, Toru Imamura, Kunitada Shimotono, Kozo Takayama, Tetsuya Yoshida, Mahito Nakanishi.   

Abstract

Persistent and stable expression of foreign genes has been achieved in mammalian cells by integrating the genes into the host chromosomes. However, this approach has several shortcomings in practical applications. For example, large scale production of protein pharmaceutics frequently requires laborious amplification of the inserted genes to optimize the gene expression. The random chromosomal insertion of exogenous DNA also results occasionally in malignant transformation of normal tissue cells, raising safety concerns in medical applications. Here we report a novel cytoplasmic RNA replicon capable of expressing installed genes stably without chromosome insertion. This system is based on the RNA genome of a noncytopathic variant Sendai virus strain, Cl.151. We found that this variant virus establishes stable symbiosis with host cells by escaping from retinoic acid-inducible gene I-interferon regulatory factor 3-mediated antiviral machinery. Using a cloned genome cDNA of Sendai virus Cl.151, we developed a recombinant RNA installed with exogenous marker genes that was maintained stably in the cytoplasm as a high copy replicon (about 4 x 10(4) copies/cell) without interfering with normal cellular function. Strong expression of the marker genes persisted for more than 6 months in various types of cultured cells and for at least two months in rat colonic mucosa without any apparent side effects. This stable RNA replicon is a potentially valuable genetic platform for various biological applications.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17623660     DOI: 10.1074/jbc.M702028200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  21 in total

1.  Nasal vaccine delivery attenuates brain pathology and cognitive impairment in tauopathy model mice.

Authors:  Hiroki Takeuchi; Keiko Imamura; Bin Ji; Kayoko Tsukita; Takako Enami; Keizo Takao; Tsuyoshi Miyakawa; Masato Hasegawa; Naruhiko Sahara; Nobuhisa Iwata; Makoto Inoue; Hideo Hara; Takeshi Tabira; Maiko Ono; John Q Trojanowski; Virginia M-Y Lee; Ryosuke Takahashi; Tetsuya Suhara; Makoto Higuchi; Haruhisa Inoue
Journal:  NPJ Vaccines       Date:  2020-03-25       Impact factor: 7.344

2.  Development of defective and persistent Sendai virus vector: a unique gene delivery/expression system ideal for cell reprogramming.

Authors:  Ken Nishimura; Masayuki Sano; Manami Ohtaka; Birei Furuta; Yoko Umemura; Yoshiro Nakajima; Yuzuru Ikehara; Toshihiro Kobayashi; Hiroaki Segawa; Satoko Takayasu; Hideyuki Sato; Kaori Motomura; Eriko Uchida; Toshie Kanayasu-Toyoda; Makoto Asashima; Hiromitsu Nakauchi; Teruhide Yamaguchi; Mahito Nakanishi
Journal:  J Biol Chem       Date:  2010-12-07       Impact factor: 5.157

3.  A respiratory syncytial virus replicon that is noncytotoxic and capable of long-term foreign gene expression.

Authors:  Olga Malykhina; Mark A Yednak; Peter L Collins; Paul D Olivo; Mark E Peeples
Journal:  J Virol       Date:  2011-03-09       Impact factor: 5.103

4.  Conserved charged amino acids within Sendai virus C protein play multiple roles in the evasion of innate immune responses.

Authors:  Takashi Irie; Natsuko Nagata; Tomoki Igarashi; Isao Okamoto; Takemasa Sakaguchi
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

5.  Evaluation of the influenza A replicon for transient expression of recombinant proteins in mammalian cells.

Authors:  Florian Krammer; Jens Pontiller; Christopher Tauer; Dieter Palmberger; Andreas Maccani; Martina Baumann; Reingard Grabherr
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.752

6.  RNA replicon delivery via lipid-complexed PRINT protein particles.

Authors:  Jing Xu; J Christopher Luft; Xianwen Yi; Shaomin Tian; Gary Owens; Jin Wang; Ashley Johnson; Peter Berglund; Jonathan Smith; Mary E Napier; Joseph M DeSimone
Journal:  Mol Pharm       Date:  2013-08-21       Impact factor: 4.939

Review 7.  Viral and Synthetic RNA Vector Technologies and Applications.

Authors:  Juliane W Schott; Michael Morgan; Melanie Galla; Axel Schambach
Journal:  Mol Ther       Date:  2016-07-05       Impact factor: 11.454

Review 8.  Pluripotent stem cells reveal the developmental biology of human megakaryocytes and provide a source of platelets for clinical application.

Authors:  Naoya Takayama; Koji Eto
Journal:  Cell Mol Life Sci       Date:  2012-04-24       Impact factor: 9.261

9.  Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells.

Authors:  Naoya Takayama; Satoshi Nishimura; Sou Nakamura; Takafumi Shimizu; Ryoko Ohnishi; Hiroshi Endo; Tomoyuki Yamaguchi; Makoto Otsu; Ken Nishimura; Mahito Nakanishi; Akira Sawaguchi; Ryozo Nagai; Kazutoshi Takahashi; Shinya Yamanaka; Hiromitsu Nakauchi; Koji Eto
Journal:  J Exp Med       Date:  2010-11-22       Impact factor: 14.307

Review 10.  Development of Sendai virus vectors and their potential applications in gene therapy and regenerative medicine.

Authors:  Mahito Nakanishi; Makoto Otsu
Journal:  Curr Gene Ther       Date:  2012-10       Impact factor: 4.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.